Literature DB >> 30797277

Tuberculosis control in India: Refocus on nutrition.

Bhagya Shaji1, E T Arun Thomas2, P K Sasidharan3.   

Abstract

Many western societies have eliminated tuberculosis years before the advent of potent anti-tuberculous drugs, as a result of the improved standards of living and good nutrition. But even with the availability of powerful anti-tuberculous drugs, India still has a long road ahead to reach the "End TB by 2025" goal. One of the major reason is that tuberculosis control program in India till now have focused primarily on case detection and medical treatment of active tuberculosis. Drug treatment alone does not completely prevent the occurrence of new infections in the community and also contributes to development of drug resistant strains if used improperly or incompletely. Although the treatment of active cases can reduce the period of transmission of disease, a significant amount of transmission to contacts occurs even before they have been diagnosed and treated. Additionally, this approach cannot prevent re-activation to active TB in the vast pool of persons with latent TB infection. Tuberculosis occurs in those with suppressed cell mediated immunity mainly due to poor nutritional status. Improving the nutritional status of the society by several social interventions hand-in-hand with utilizing the available anti-tuberculous drugs is possibly the only effective strategy. Promising programmatic guidance for nutritional support in TB patients have been formulated by the Central TB division of India but it needs a refocusing of TB control strategies towards nutrition at all levels and strong public health actions for effective implementation.
Copyright © 2018 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Nutrition; TB control; Tuberculosis; Vitamin D

Year:  2018        PMID: 30797277     DOI: 10.1016/j.ijtb.2018.10.001

Source DB:  PubMed          Journal:  Indian J Tuberc        ISSN: 0019-5707


  3 in total

1.  Computational design of MmpL3 inhibitors for tuberculosis therapy.

Authors:  R Chaitra; Rohit Gandhi; N Jayanna; Sachin Satyanath; Parasuraman Pavadai; Manikanta Murahari
Journal:  Mol Divers       Date:  2022-04-28       Impact factor: 2.943

2.  Improvement of Nutritional Status among Tuberculosis Patients by Channa striata Supplementation: A True Experimental Study in Indonesia.

Authors:  Isa Ma'rufi; Khaidar Ali; Sigit Kusuma Jati; Anik Sukmawati; Kurnia Ardiansyah; Farida Wahyu Ningtyias
Journal:  Biomed Res Int       Date:  2020-01-11       Impact factor: 3.411

3.  Prevalence and determinants of TB infection in a rural population in northeastern Myanmar.

Authors:  Theint Theint Lwin; Tawatchai Apidechkul; Jongkon Saising; Panupong Upala; Ratipark Tamornpark; Chalitar Chomchoei; Fartima Yeemard; Wipob Suttana; Rachanee Sunsern
Journal:  BMC Infect Dis       Date:  2020-11-30       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.